Engineering study comparing injection force and dose accuracy between two prefilled insulin injection pens

Current Medical Research and Opinion

Volumn 25, Issue 12, 2009, Pages 2829-2833

  Ignaut, Debra A ^a   Opincar, Michael R ^a   Clark, Paula E ^a   Palaisa, Melanie K ^b   Lenox, Sheila M ^b  

^a ELI LILLY AND COMPANY   (United States)

^b Lilly USA   (United States)

Author keywords

Dose accuracy; Glide force; Glide force variability; Injection force; Insulin pen

Indexed keywords

INSULIN ASPART; INSULIN LISPRO;

ACCURACY; ARTICLE; BIOENGINEERING; COMPARATIVE STUDY; CONTROLLED STUDY; DRUG DELIVERY SYSTEM; ERROR; FORCE; INJECTION; INJECTION PEN; INSULIN TREATMENT; VELOCITY;

BIOMECHANICS; BIOMEDICAL ENGINEERING; DISPOSABLE EQUIPMENT; DOSAGE FORMS; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG DOSAGE CALCULATIONS; HUMANS; INJECTIONS; INSULIN; MEDICATION ERRORS; TIME FACTORS;

EID: 72549105732     PISSN: 03007995     EISSN: 14734877     Source Type: Journal    
DOI: 10.1185/03007990903327993     Document Type: Article

References (16)

1. Korytkowski M, Bell D, Jacobsen C, et al.; FlexPen Study Team. A multicenter, randomized, open-label, comparative, two-period crossover trial of preference, efficacy, and safety profiles of a prefilled, disposable pen and conventional vial/syringe for insulin injection in patients with type 1 or 2 diabetes mellitus. Clin Ther 2003;25:2836-2848
2. Molife C, Lee LJ, Shi L, et al. Review: assessment of patient reported outcomes of insulin pen devices versus conventional vial and syringe. Diabetes Technol Ther 2009;11:529-538
3. Ignaut DA, Schwartz SL, Sarwat S, et al. Comparative device assessments: KwikPen compared with vial and syringe and FlexPen. Diabetes Educ 2009;35:789-798
4. Coscelli C, Lostia S, Lunetta M, et al. Safety, efficacy, acceptability of a prefilled insulin pen in diabetic patients over 60 years old. Diabetes Res Clin Pract 1995;28:1737
5. Da Costa S, Brackenridge B, Hicks D. A comparison of insulin pen use in the United States and the United Kingdom. Diabetes Educ 2002;28:52-60
6. Kadiri A, Chraibi A, Marouan F, et al. Comparison of NovoPen 3 and syringes/vials in the acceptance of insulin therapy in NIDDM patients with secondary failure to oral hypoglycaemic agents. Diabetes Res Clin Pract 1998;41:15-23 (Pubitemid 28394280)
7. Toraishi K, Yuizono Y, Nakamura N, et al. Force requirements and insulin delivery profiles of four injection devices. Diabetes Technol Ther 2005;7:629-635 (Pubitemid 41208627)
8. Pfützner A, Reimer T, Hohberg C, et al. Prefilled insulin device with reduced injection force: patient perception and accuracy. Curr Med Res Opin 2008;24:2545-2549
9. Hänel H, Weise A, Sun W, et al. Differences in the dose accuracy of insulin pens. J Diabetes Sci Technol 2008;2:478-481
10. Ignaut DA, Opincar M, Lenox SM. FlexPen and KwikPen prefilled insulin devices: a laboratory evaluation of ergonomic and injection force characteristics. J Diabetes Sci Technol 2008;2:533-537
11. Clarke A, Spollett G. Dose accuracy and injection force dynamics of a novel disposable insulin pen. Expert Opin Drug Deliv 2007;4:165-174 (Pubitemid 46389914)
12. Haak T, Edelman S, Walter C, et al. Comparison of usability and patient preference for the new disposable insulin device SoloStar versus FlexPen, Lilly disposable pen, and a prototype pen: an open-label study. Clin Ther 2007;29:650-660
13. Iwanaga M, Kamoi K. Patient perception of injection pain and anxiety: a comparison of NovoFine 32-gauge top 6mm and Micro Fine Plus 31-gauge 5mm needles. Diabetes Technol Ther 2009;00:1181-1186
14. Rissler J, Jørgensen C, Hansen MR, et al. Evaluation of the injection force dynamics of a modified prefilled insulin pen. Expert Opin Pharmacother 2008;9:2217-2222
15. Asakura T, Seino H, Kageyama M, et al. Evaluation of injection force of three insulin delivery pens. Expert Opin Pharmacother 2009;10:1389-1393
16. Owens DR. Study to compare the injection force required for the following insulin pen devices: Lilly disposable pen, Novo FlexPen, and SoloStar. J Diabetes Sci Tech 2007;1:A134